Stay updated on Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.

Latest updates to the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page
- Check4 days agoChange DetectedRecruitment status on the study page has been updated to 'No longer looking for participants', signaling that enrollment is closed. The page also adds new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and updates the revision label to v3.6.0.SummaryDifference0.5%

- Check11 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5, indicating a new version of the page. This is a metadata update and does not modify the study content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, representing a small update to the page’s underlying template or software. This change does not alter study content or visible functionality.SummaryDifference0.1%

- Check54 days agoChange DetectedThis updates the displayed revision/version indicator for the page from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check61 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check90 days agoChange DetectedFooter revision label updated to v3.5.0. The previous v3.4.3 label was removed.SummaryDifference0.1%

Stay in the know with updates to Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.